An independent editorial resource for understanding the real cost of online compounded GLP-1 treatment.
GLP-1 Price Guide is an independent editorial resource built to help patients understand the real cost of online weight-loss treatment with compounded GLP-1 medications. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment.
"Compare the real GLP-1 cost — not just the advertised starter price."
The compounded GLP-1 market grew rapidly in 2024-2025 during the FDA semaglutide and tirzepatide shortages. Many telehealth providers advertise low "starting at" prices that don't reflect true monthly cost after dose escalation, refills, and membership fees. We exist to make the real cost visible.
GLP-1 Price Guide is an editorial publication. We do not accept paid placements that influence our pricing analysis or transparency assessments. If we maintain an affiliate, sponsorship, or material relationship with any provider mentioned, that relationship is disclosed on the relevant page.
Pricing is re-verified the 1st of each month from publicly available provider pages and third-party references. We do not invent pricing numbers; every figure cited is sourced. Where a provider has not disclosed pricing publicly, we mark it "verify" rather than guess.
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. We avoid equivalence claims and avoid recommending unlicensed "research peptide" vendors. We support patient-physician decision-making, not direct-to-consumer prescribing.
Editorial inquiries, corrections, and pricing updates: glponepriceguide@gmail.com